The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,733.50
Bid: 1,732.50
Ask: 1,733.00
Change: 0.00 (0.00%)
Spread: 0.50 (0.029%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1,733.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 2-JD Sports leads FTSE 100 higher, rate cut hopes support

Tue, 10th Sep 2019 09:46

* FTSE 100 up 0.4%, FTSE 250 up 0.3%

* JD Sports hits life high after profit rise

* Galliford jumps on deal talks

* 888 skids as earnings hit by higher tax, Brexit-related
expenses
(Adds new items, analyst comments, updates to closing prices)

By Muvija M and Shashwat Awasthi

Sept 10 (Reuters) - London's FTSE 100 overcame early losses
to close higher on Tuesday as hopes of imminent interest rate
cuts from major central banks buoyed sentiment, while JD Sports
jumped to an all-time high on upbeat results.

The blue-chip index added 0.4%, with JD Sports
gaining 8.8% after its gym clothing and premium-branded
fashion helped it post higher profit and offset UK retail sector
gloom.

The FTSE 250 rose 0.3%, helped in part by a nearly
13% surge in Cairn Energy as strong half-year results
led to a production target upgrade.

In a sign of ongoing rotation, investors dumped defensive
shares and bought stocks of sectors that have underperformed
this year, helping an index of banks climb 2.4% for
its best day since January.

Shares of Lloyds and Barclays rose 4.3%
and 4.9%, respectively, while healthcare stocks GlaxoSmithKline
and AstraZeneca shed more than 2% each.

UK markets also looked past disappointing data from China
overnight that had added to fears of a global recession.

Speculation that the European Central Bank will cut interest
rates this week and that the U.S. Federal Reserve will follow
suit later this month in the face of slowing economic growth
helped stoke some risk appetite.

"Seeing as the ECB are tipped to go down the path of an
interest rate cut, stocks are likely to be buoyant between now
and the announcement," CMC Markets analyst David Madden said.

Oil heavyweights Shell and BP were the
biggest boosts to the main index as they tracked a rise in crude
prices on hopes that OPEC and other oil-producing countries may
agree to extend output cuts to prop up prices.

Mid-cap builder Galliford Try advanced 8% after it
restarted preliminary talks to sell its residential housing
businesses to Bovis Homes.

Bovis, whose shares dropped 3.5%, nudged up its proposed
offer and included a cash element, which Markets.com analyst
Neil Wilson said would be "a welcome injection for the newly
reorganised Galliford construction division."

Among small-caps, online gambling firm 888 Holdings
slumped 8.6%, its worst day in almost a year, after results
showed a hit to earnings from a rise in online gaming taxes and
administrative expenses due to Brexit preparations.
(Reporting by Muvija M in Bengaluru; Editing by Arun Koyyur and
Dan Grebler)

More News
12 Feb 2024 08:35

TOP NEWS: GSK's bepirovirsen receives US FDA fast track designation

(Alliance News) - GSK PLC on Monday said that the US health watchdog granted fast track designation for its bepirovirsen treatment for chronic hepatitis B.

Read more
12 Feb 2024 07:50

LONDON BRIEFING: Tritax Big Box, UK Commercial Property agree merger

(Alliance News) - Equities in London are called to open higher on Monday, with inflation readings from the US and UK on the horizon, which could drive equity market sentiment during the remainder of the week.

Read more
12 Feb 2024 07:21

GSK gets FDA fast track for chronic hepatitis B treatment

(Sharecast News) - GSK announced on Monday that bepirovirsen, an investigational antisense oligonucleotide (ASO) aimed at treating chronic hepatitis B (CHB), had been granted fast track designation by the US Food and Drug Administration (FDA).

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
6 Feb 2024 08:51

TOP NEWS: GSK reports positive news on trio of high profile products

(Alliance News) - GSK PLC on Tuesday delivered a triple dose of positive updates on some of its leading products, Arexvy, Shingrix and Blencep.

Read more
6 Feb 2024 07:47

LONDON BRIEFING: BP promises buyback despite drop in profit

(Alliance News) - Stocks in London are called to open higher, ahead of a slew of construction purchasing managers' index readings from the eurozone, the UK and Germany.

Read more
6 Feb 2024 07:23

GSK reports positive myeloma trial results, progresses vaccine applications

(Sharecast News) - GSK reported progress in its trial of a myeloma treatment on Tuesday, as well as regulatory progress around its shingles vaccine in China and its RSV vaccine in the United States.

Read more
1 Feb 2024 09:27

TOP NEWS: GSK maintains "vigorous" defence after settling Zantac case

(Alliance News) - GSK PLC on Thursday insisted upon its scientific integrity, after reaching another settlement in ongoing litigation over alleged links between its heartburn drug and cancer.

Read more
1 Feb 2024 09:11

GSK settles Zantac case in California without admitting liability

(Sharecast News) - GSK announced on Thursday that it had reached a confidential settlement to effectively resolve the legal case over Zantac filed in a California state court.

Read more
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.